Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.

Clinical trial NCT01933035 · COMPLETED

Trial details

NCT number: NCT01933035
Sponsor: Beth Israel Medical Center
Status: COMPLETED
Study type: OBSERVATIONAL

Immune Thrombocytopenia Chemotherapy Induced Thrombocytopenia Myelodysplasia Aplastic Anaemia

Start date: 2013-10-01
Primary completion: 2015-10-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.